EnteroMedics Inc.
The development-stage medical device company,EnteroMedics Inc. uses neuroblocking technology called VBLOC therapy to combat obesity. Its initial product in development, the Maestro System, is a device laparoscopically implanted near the diaphragm that uses electrical impulses to limit the expansion of the stomach, thereby producing a feeling of prolonged fullness. The Maestro System is in US and international clinical trials, with FDA approval and commercial sales anticipated by 2010. EnteroMedics plans to build a direct sales force to market the product to bariatric surgeons and weight management specialists.
Contact Details
Office Address
EnteroMedics Inc.
2800 Patton Road
St. Paul, MN, USA 55113
Phone: (651) 634-3003
Executives
President and CEO
Mark B. Knudson
SVP Operations
Adrianus (Jos) Donders